Direct and mediated ties to universities: ‘Scientific’ absorptive capacity and innovation performance of pharmaceutical firms

Rene Belderbos, Victor Gilsing and Shinya Suzuki

No 504836, Working Papers of Department of Management, Strategy and Innovation, Leuven from KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven

Abstract: Extant literature on firm-university collaboration has emphasized two different strategies that firms in science based industries adopt in order to source scientific knowledge and expertise. On the one hand, firms engage in direct research collaborations with universities. On the other hand, firms establish indirect, mediated, ties to universities by engaging in research collaborations with dedicated biotech firms (DBFs) that are themselves strongly linked to universities - with the DBF taking the role of ‘broker’. We argue that the relative benefits of direct and mediated ties depend on the extent to which firms have organized their R&D to facilitate the absorption, assimilation, transformation and exploitation of scientific knowledge, which we coin ‘scientific absorptive capacity’. Drawing on patent and publication data in a panel of 33 vertically integrated pharmaceutical firms, we find that direct university collaboration is more beneficial for firms with relatively high scientific absorptive capacity, while only mediated ties are associated with greater innovative performance for firms with relatively low scientific absorptive capacity. The latter association is reduced if the mediated ties are with top universities. Our findings are suggestive of the importance of a ‘fit’ between the nature of a firm’s R&D organization and its strategy to access scientific knowledge.

Keywords: R&D collaboration; alliance portfolios; industry-science linkages; scientific; alliance portfolios; industry-science linkages; scientific absorptive capacity (search for similar items in EconPapers)
Date: 2015-08
References: Add references at CitEc
Citations:

Published in FEB Research Report - MSI_1510

Downloads: (external link)
https://lirias.kuleuven.be/retrieve/330389 MSI_1510 (application/pdf)

Related works:
Working Paper: DIRECT AND MEDIATED TIES TO UNIVERSITIES: ‘SCIENTIFIC’ ABSORPTIVE CAPACITY AND INNOVATION PERFORMANCE OF PHARMACEUTICAL FIRMS (2015)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ete:msiper:504836

Access Statistics for this paper

More papers in Working Papers of Department of Management, Strategy and Innovation, Leuven from KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven
Bibliographic data for series maintained by library EBIB ().